Levitronix, headquartered in Massachusetts (USA) and Zurich (Switzerland), carried out a corporate restructuring and sold its medical business to Thoratec Corporation. The lead commercial product of Levitronix Medical is a blood flow pump used for short-term surgical support.
Bär & Karrer acted as Swiss counsel to Levitronix with respect to the restructuring and the sale of the medical business to Thoratec. The Bär & Karrer team included Ralph Malacrida (corporate), Raoul Stocker (tax), Markus Wang (IP), Thomas Stoltz (corporate), Birgit Urbons (corporate) and Michael Barrot (tax).